Ad is loading...

CRMD CorMedix Forecast, Technical & Fundamental Analysis

a developer of medical devices for cardiovascular and kidney diseases

Industry Biotechnology

Get AI intraday signals

CRMD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRMD
(Try 14 days for Free)

View a ticker or compare two or three

Compare

CRMD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRMD
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

CRMD is expected to report earnings to fall 60.00% to -1 cents per share on April 01

Q4'24

Est.

$-0.02

Q3'24

Beat

by $0.06

Q2'24

Est.

$-0.25

Q1'24

Beat

by $0.01

Q4'23

Missed

by $0.07

The last earnings report on October 30 showed earnings per share of -5 cents, beating the estimate of -10 cents. With 357.30K shares outstanding, the current market capitalization sits at 671.70M.

A.I. Advisor

published General Information

General Information

a developer of medical devices for cardiovascular and kidney diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

300 Connell Drive

Phone

+1 908 517-9500

Employees

Web

https://www.cormedix.com

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
PEIJX	44.43	0.03	+0.07%
Principal Equity Income J
HRLVX	24.14	N/A	N/A
Harbor Large Cap Value Admin
HWAZX	42.05	N/A	N/A
Hotchkis & Wiley Value Opps Z
ARIOX	15.44	N/A	N/A
Aristotle/Saul Global Eq I
MELSX	15.86	-0.01	-0.06%
Morgan Stanley Inst EMkts Ldrs R6

CRMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with ANAB. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then ANAB could also see price increases.

Ticker / NAME	Correlation To CRMD	1D Price Change %
CRMD	100%	-2.98%
ANAB - CRMD	42% Loosely correlated	+1.70%
PGEN - CRMD	35% Loosely correlated	+5.17%
ARTL - CRMD	33% Poorly correlated	+3.60%
SAGE - CRMD	33% Poorly correlated	N/A
VERU - CRMD	32% Poorly correlated	-0.30%
More